Published in J Immunol on July 15, 1993
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A (2006) 3.13
Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci U S A (2001) 2.63
Ion channels in innate and adaptive immunity. Annu Rev Immunol (2015) 1.99
Extracellular K(+) and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and beta1 integrins. J Exp Med (2000) 1.52
Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation. J Exp Med (2002) 1.07
A mathematical model of T lymphocyte calcium dynamics derived from single transmembrane protein properties. Front Immunol (2013) 0.82
Direct influence of the sodium pump on the membrane potential of vomeronasal chemoreceptor neurones in frog. J Physiol (1996) 0.80
Roles of lymphocyte kv1.3-channels in the pathogenesis of renal diseases and novel therapeutic implications of targeting the channels. Mediators Inflamm (2015) 0.77
Differences in ion channel phenotype and function between humans and animal models. Front Biosci (Landmark Ed) (2018) 0.77
Effect of the Kv1.3 voltage-gated potassium channel blocker PAP-1 on the initiation and progress of atherosclerosis in a rat model. Heart Vessels (2014) 0.76
Mechanism of functional interaction between potassium channel Kv1.3 and sodium channel NavBeta1 subunit. Sci Rep (2017) 0.75
Increased risk of lymphoma in sicca syndrome. Ann Intern Med (1978) 4.63
Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med (1980) 3.81
Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest (1984) 2.88
Early T lymphocytes. Differentiation in vivo of adult intrathymic precursor cells. J Exp Med (1985) 2.81
Ferrous-activated nicotinamide adenine dinucleotide-linked dehydrogenase from a mutant of Escherichia coli capable of growth on 1, 2-propanediol. J Bacteriol (1969) 2.66
Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc Natl Acad Sci U S A (1987) 2.57
Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction. J Immunol (1974) 2.45
Expression of Lyt-1 by a subset of B lymphocytes. J Immunol (1982) 2.41
Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus. J Exp Med (1974) 2.40
Demonstration of activation of B lymphocytes in New Zealand black mice at birth by an immunoradiometric assay for murine IgM. J Immunol (1977) 2.06
XenCSA: cell surface antigens related to the major glycoproteins (gp70) of xenotropic murine leukemia viruses. J Immunol (1979) 2.02
Genetic differences between primary and secondary sicca syndrome. N Engl J Med (1979) 1.93
Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med (1979) 1.79
The clearance and localization of nucleic acids by New Zealand and normal mice. Clin Exp Immunol (1972) 1.74
Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice. J Immunol (1975) 1.62
Lymphocyte membrane potential and Ca2+-sensitive potassium channels described by oxonol dye fluorescence measurements. J Cell Physiol (1985) 1.52
Differential expression of two distinct xenotropic viruses in NZB mice. Clin Immunol Immunopathol (1980) 1.48
Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Correlation with clinical features. Am J Med (1982) 1.46
Demonstration of circulating immune complexes in Sjögren's syndrome. J Immunol (1979) 1.46
Supressor cells in the graft vs host reaction. J Immunol (1973) 1.41
Enhanced antibody response of mice to polyinosinic-polycytidylic acid by antithymocyte serum and its age-dependent loss in NZB-W mice. J Immunol (1973) 1.40
Studies of congenic MRL-Ipr/Ipr.xid mice. J Immunol (1983) 1.38
Responder cells in the human autologous mixed lymphocyte reaction. J Clin Invest (1981) 1.37
Aluminum fluoride induces phosphatidylinositol turnover, elevation of cytoplasmic free calcium, and phosphorylation of the T cell antigen receptor in murine T cells. J Immunol (1987) 1.36
Wild mouse ecotropic murine leukemia virus infection of inbred mice: dual-tropic virus expression precedes the onset of paralysis and lymphoma. J Virol (1981) 1.35
Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture. J Clin Invest (1982) 1.33
Sjögren's syndrome association with HLA-Dw3. N Engl J Med (1977) 1.32
Immunofluorescence studies on thymocytotoxic antibody from New Zealand Black mice. J Immunol (1974) 1.31
The human autologous mixed lymphocyte reaction. III. Immune circuits. J Immunol (1982) 1.27
Sjögren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med (1977) 1.27
Human neutrophil heterogeneity identified using flow microfluorometry to monitor membrane potential. J Clin Invest (1981) 1.26
Proliferation of infected lymphoid precursors before Moloney murine leukemia virus-induced T-cell lymphoma. J Natl Cancer Inst (1985) 1.25
Purification of an acidic nuclear protein antigen and demonstration of its antibodies in subsets of patients with sicca syndrome. J Immunol (1977) 1.22
Phenotypic and functional effects of the motheaten gene on murine B and T lymphocytes. J Immunol (1979) 1.20
Macrophage requirement for the in vitro response to TNP Ficoll: a thymic independent antigen. J Immunol (1976) 1.19
A proposal for a flow cytometric data file standard. Cytometry (1984) 1.18
The B lymphocyte calcium response to anti-Ig is diminished by membrane immunoglobulin cross-linkage to the Fc gamma receptor. J Immunol (1987) 1.13
CBA/N X-linked B-cell defect prevents NZB B-cell hyperactivity in F1 mice. J Exp Med (1979) 1.12
Genetic and functional analyses of the primary in vitro CTL: response of NZB lymphocytes to H-2-compatible cells. Immunogenetics (1981) 1.12
Differentiation antigens identify subpopulations of rabbit T and B lymphocytes. Definition by flow cytometry. J Exp Med (1983) 1.11
Eosinophil autofluorescence and its use in isolation and analysis of human eosinophils using flow microfluorometry. Blood (1981) 1.11
A quantitative fluorescent method for measurement of bacterial adherence and phagocytosis. J Immunol Methods (1986) 1.07
Expression of xenotropic murine leukemia viruses as cell-surface gp70 in genetic crosses between strains DBA/2 and C57BL/6. J Exp Med (1979) 1.03
Biotinylation of human C3. Mol Immunol (1982) 1.02
Antibody to a soluble acidic nuclear antigen in Sjögren's syndrome. Am J Med (1977) 1.01
Heterogeneity of lymphocyte calcium metabolism is caused by T cell-specific calcium-sensitive potassium channel and sensitivity of the calcium ATPase pump to membrane potential. J Exp Med (1988) 1.00
Studies of lymphoproliferation in MRL-lpr/lpr mice. J Immunol (1984) 0.99
Flow cytometric analysis of murine splenic B lymphocyte cytosolic free calcium response to anti-IgM and anti-IgD. Cytometry (1987) 0.97
Identification of cells infiltrating the minor salivary glands in patients with Sjögren's syndrome. J Immunol (1974) 0.96
Immune complex glomerulonephritis in sicca syndrome. Am J Med (1978) 0.95
Fixation and long-term storage of human lymphocytes for surface marker analysis by flow cytometry. Cytometry (1988) 0.95
Effects of extracellular ATP and adenosine on different thymocyte subsets: possible role of ATP-gated channels and G protein-coupled purinergic receptor. J Immunol (1997) 0.92
Cytotoxic activity of anti-theta antibody found in the gamma m fraction. Transplantation (1974) 0.91
Cyclophosphamide-induced changes in the MRL-lpr/lpr mouse: effects upon cellular composition, immune function, and disease. Clin Immunol Immunopathol (1984) 0.91
Evidence for thymic regulation of autoimmunity in BXSB mice: acceleration of disease by neonatal thymectomy. J Immunol (1983) 0.91
Production and characterization of monoclonal antibodies to guinea pig lymphoid differentiation antigens. J Immunol Methods (1983) 0.90
Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res (1983) 0.90
HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens. Ann Rheum Dis (1987) 0.90
Systemic lupus erythematosus: delineation of subpopulations by clinical, serologic, and T cell subset analysis. Am J Med Sci (1985) 0.90
B lymphocyte antigens in sicca syndrome. Science (1978) 0.89
Differential binding of chemoattractant peptide to subpopulations of human neutrophils. J Immunol (1984) 0.89
Increased frequency of HL-A8 in Sjogren's syndrome. Tissue Antigens (1975) 0.88
Voltage-sensitive cyanine dye fluorescence signals in lymphocytes: plasma membrane and mitochondrial components. J Cell Physiol (1985) 0.88
Characterization of T lymphocyte and monocyte populations in HLA B8/DRw3 normal individuals and in patients with dermatitis herpetiformis. J Invest Dermatol (1984) 0.88
In vitro and in vivo cytotoxicity to EL-4 sarcoma in New Zealand mice. J Immunol (1974) 0.88
Immunoregulatory disorders associated with hereditary angioedema. II. Serologic and cellular abnormalities. J Allergy Clin Immunol (1986) 0.87
Genetic control of B- and T-lymphocyte abnormalities of NZB mice in crosses with B10.D2 mice. Immunogenetics (1981) 0.87
Chromosome 1 locus required for induction of CTL to H-2-compatible cells in NZB mice. Immunogenetics (1982) 0.87
The effect of the X-linked immune deficiency gene (xid) upon the Y chromosome-related disease of BXSB mice. J Immunol (1983) 0.86
Primary Sjogren's syndrome and autoimmune hemolytic anemia in sisters. A family study. Am J Med (1983) 0.86
Expression on normal lymphocytes of two cell surface antigens, XenCSA and GIX, related to the major glycoproteins (gp70) of murine leukemia viruses. J Immunol (1982) 0.84
T cell receptor-mediated recognition of self-ligand induces signaling in immature thymocytes before negative selection. J Exp Med (1992) 0.84
Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice. J Immunol (1986) 0.84
Two defects in old New Zealand Black mice are involved in the loss of low-dose paralysis to type III pneumococcal polysaccharide. J Immunol (1985) 0.84
Sex and H-2 haplotype control the resistance of CBA-BALB hybrids to the induction of T cell lymphoma by Moloney leukemia virus. J Immunol (1984) 0.82
Variations in expression of xenotropic murine leukemia virus genomes in lymphoid tissues of NZB mice. J Immunol (1979) 0.82
Increased amplifier T cell activity in autoimmune NZB mice and its possible significance in the expression of autoimmune disease. Immunobiology (1986) 0.81
Ly-2+ T cell enlargement and null cell proliferation occur at the onset of splenomegaly and autoantibody production in New Zealand Black mice. J Immunol (1984) 0.81
Cyclophosphamide tolerance as a test for antigenicity of nucleic acids. Nature (1970) 0.81
Two separate mechanisms of T cell clonal anergy to Mls-1. J Immunol (1993) 0.80
Immune cell cooperation, viruses, and antibodies to nucleic acids in New Zealand mice. J Exp Med (1971) 0.80
Submucous fibrosis. Oral Surg Oral Med Oral Pathol (1974) 0.80
Isolation of human basophils by flow microfluorometry. J Immunol Methods (1983) 0.79
Induction of proliferation by high molecular weight B cell growth factor or low molecular weight B cell growth factor is associated with increases in intracellular calcium in different subpopulations of human B lymphocytes. Cell Immunol (1991) 0.79
Multigenic basis of autoimmune disease in New Zealand mice. Concepts Immunopathol (1987) 0.79
Analysis of B-cell subpopulations. I. Relationships among splenic xid, Ly 1+, and Lyb 5+ B cells. Cell Immunol (1985) 0.78
A new xenogenic monoclonal antibody detecting class I H-2 molecules. Immunogenetics (1982) 0.78
Cellular distribution of a human I-A-like (DS/DC) antigen on normal and neoplastic lymphoid cells. Hum Immunol (1985) 0.78
Murine splenic null cell compartment contains distinct haemopoietic subpopulations: enlargement of a myeloid and an undifferentiated subset with the development of splenomegaly in New Zealand black mice. Immunology (1992) 0.77
Comparison of response to stem cell differentiation signals between normal and autoimmune mouse strains. J Immunol (1985) 0.77
Analysis of lymphocyte proteins from New Zealand black mice by two-dimensional gel electrophoresis. J Immunol (1985) 0.75
Antagonism of vasoactive amines in NZB-W glomerulonephritis. I. Beneficial effect of methysergide. Proc Soc Exp Biol Med (1973) 0.75
Optical measurement in single cells of membrane potential changes linked to T and B lymphocyte antigen receptors. Soc Gen Physiol Ser (1988) 0.75
Antigen-specific cell conjugate formation and long-lasting calcium responses in recognition of Mls cellular superantigen by cloned murine T lymphocytes. Cell Immunol (1994) 0.75
Impairment of primary in vitro response of New Zealand mouse spleen cells to a thymic-dependent antigen. Cell Immunol (1977) 0.75
Selective elimination of lymphocyte subpopulations by monoclonal antibody-enzyme conjugates. J Immunol Methods (1985) 0.75
Effects of induced anemia in normal and autoimmune mice. Immunol Invest (1990) 0.75
Increased number of Leu-2-bearing non-T cells with natural killer activity in chimpanzees. Cell Immunol (1986) 0.75
Enlargement of Lyt-2-positive T cells is associated with functional impairment and autoimmune hemolytic anemia in New Zealand Black mice. J Immunol (1985) 0.75